Eric Lefebvre - 23 Jan 2025 Form 4 Insider Report for PLIANT THERAPEUTICS, INC. (PLRX)

Role: Chief Medical Officer
Signature: /s/ Jennifer Woo, attorney-in-fact
Issuer symbol: PLRX
Transactions as of: 23 Jan 2025
Net transactions value: $0
Form type: 4
Filing time: 27 Jan 2025, 18:04:15 UTC
Previous filing: 22 Jan 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PLRX	Common Stock	Award	$0	+45,650	+23%	$0.000000	240,224	23 Jan 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PLRX	Stock Option (Right to Buy)	Award	$0	+91,300		$0.000000	91,300	23 Jan 2025	Common Stock	91,300	$11.14	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These are restricted stock units that vest in three substantially equal annual installments beginning January 16, 2025, subject to the Reporting Person's continuous service to the Issuer on each such date.
F2	1/48th of the shares subject to such option vest and become exercisable in substantially equal installments on each monthly anniversary of January 1, 2025, subject to the Reporting Person's continuous service to the Issuer on each such date.